These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 10551896)
1. Abnormal vasoreactivity in the pathophysiology of persistent pulmonary hypertension of the newborn. Abman SH Pediatr Rev; 1999 Nov; 20(11):e103-9. PubMed ID: 10551896 [No Abstract] [Full Text] [Related]
2. Persistent pulmonary hypertension of the newborn. Role of nitric oxide and endothelin in pathophysiology and treatment. Steinhorn RH; Millard SL; Morin FC Clin Perinatol; 1995 Jun; 22(2):405-28. PubMed ID: 7671545 [TBL] [Abstract][Full Text] [Related]
3. Inhaled nitric oxide for treatment of pulmonary artery hypertension in the newborn and infant. Roberts JD Crit Care Med; 1993 Sep; 21(9 Suppl):S374-6. PubMed ID: 8365236 [No Abstract] [Full Text] [Related]
4. Nitric oxide therapy for persistent pulmonary hypertension of the newborn. Miller CL Neonatal Netw; 1995 Dec; 14(8):9-15. PubMed ID: 8552021 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension. Abman SH Curr Opin Pediatr; 1994 Jun; 6(3):239-47. PubMed ID: 8061732 [TBL] [Abstract][Full Text] [Related]
7. Clinical pathophysiology of persistent pulmonary hypertension of the newborn and the role of inhaled nitric oxide therapy. Kinsella JP; Abman SH J Perinatol; 1996; 16(2 Pt 2 Su):S24-7. PubMed ID: 8732545 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension. Dukarm RC; Morin FC; Russell JA; Steinhorn RH Pediatr Res; 1998 Dec; 44(6):831-7. PubMed ID: 9853914 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide: biological role and clinical uses. Kannan MS; Guiang S; Johnson DE Indian J Pediatr; 1998; 65(3):333-45. PubMed ID: 10771982 [TBL] [Abstract][Full Text] [Related]
10. Persistent pulmonary hypertension of the newborn. Thérèse P Paediatr Respir Rev; 2006; 7 Suppl 1():S175-6. PubMed ID: 16798554 [TBL] [Abstract][Full Text] [Related]
11. Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: the physiology matters! Abman SH; Kinsella JP Pediatrics; 1995 Dec; 96(6):1153-5. PubMed ID: 7491241 [No Abstract] [Full Text] [Related]
12. Mechanisms of abnormal vasoreactivity in persistent pulmonary hypertension of the newborn infant. Abman SH; Ivy DD; Ziegler JW; Kinsella JP J Perinatol; 1996; 16(2 Pt 2 Su):S18-23. PubMed ID: 8732544 [No Abstract] [Full Text] [Related]
18. Intravenous prostacyclin in the treatment of persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide. Golzand E; Bar-Oz B; Arad I Isr Med Assoc J; 2005 Jun; 7(6):408-9. PubMed ID: 15984391 [No Abstract] [Full Text] [Related]
19. Growth of the vascular tree. Hislop AA; Pierce CM Paediatr Respir Rev; 2000 Dec; 1(4):321-7. PubMed ID: 16263459 [TBL] [Abstract][Full Text] [Related]
20. The role of nitric oxide in respiratory disease. Marriott H; Higenbottam T Schweiz Med Wochenschr; 1997 Apr; 127(17):709-14. PubMed ID: 9151367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]